Volume 9, Issue 13 (December 2017)

ISSN Print: 1949-4998   ISSN Online: 1949-5005

Google-based Impact Factor: 0.86  Citations  

Evaluation of Medical Costs of Kidney Diseases and Risk Factors in Japan

HTML  XML Download Download as PDF (Size: 418KB)  PP. 1734-1749  
DOI: 10.4236/health.2017.913127    923 Downloads   2,600 Views   Citations


Background: Kidney (renal) diseases and dialysis are among the most costly disorders and represent a worldwide burden. In this study, we evaluate the medical costs for individuals with kidney diseases and risk factors for the diseases in Japan. Data and Methods: The dataset used contained 113,979 medical checkups and 3,172,066 medical cost records obtained from 48,022 individuals in one health insurance society. The sample period was April 2013 to March 2016. We evaluated the distribution of all medical costs, and those of kidney diseases specifically. Then the power transformation Tobit model was used to remove the effects of other variables. Finally, a probit analysis was used to analyze the risk factors. Results: In 0.25% of all cases, individuals were diagnosed with kidney diseases. An individual with kidney disease cost 14.5 times more than those without kidney disease. If the diseases progressed into chronic kidney disease (CKD), the medical costs increased substantially. Even disregarding various characteristics of individuals, this conclusion did not vary. We found important risk factors included diabetes and blood pressure problems. In particular, an individual with both factors had a high probability of developing kidney disease. Conclusion: Kidney diseases are much costlier than other diseases. Screening high-risk individuals, educating patients, and ensuring that treatment begins at an early stage are critically important to controlling medical costs. Limitations: The dataset was observatory, and the sample period was only 3 years.

Cite this paper

Nawata, K. and Kimura, M. (2017) Evaluation of Medical Costs of Kidney Diseases and Risk Factors in Japan. Health, 9, 1734-1749. doi: 10.4236/health.2017.913127.

Cited by

[1] Эпидемиология хронической болезни почек среди жителей города Москвы
[2] International Comparisons of Economic Burden of End-Stage Renal Disease to the National Healthcare Systems.
[3] International Comparisons of Economic Burden of EndStage Renal Disease to the National Healthcare Systems
[4] Economic burden of ESRD to the Malaysian health care system
[5] Empirical Studies of Effects of High Blood Pressure on Medical Costs and Heart Disease: Is the 2017 ACC/AHA Guideline Supported by Enough Evidence?
[6] Does High Systolic Blood Pressure Truly Increase Medical Expenditure?—An Empirical Analysis of the New 2017 ACC/AHA Hypertension Guideline
[7] Evaluation of Blood Pressure Control Medicines Using Health and Medical Checkup Data in Japan: Alternative Methods for Randomized Controlled Trials

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.